Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2

Status

Unknown 2Completed 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Thoracic 1

Conditions

Lymphoma, Follicular 4Asthma 3Pulmonary Disease, Chronic Obstructive 1Bronchial Hyperreactivity 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Fluticasone-Salmeterol Drug Combination × Clear all
NCT03387241 2019-04-29

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Unknown
330 enrolled
Lymphoid

Asthma, Lymphoma, Follicular

NCT03745261 2018-11-19

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Henan University of Traditional Chinese Medicine

Phase 3 Unknown
240 enrolled
Lymphoid

Lymphoma, Follicular, Pulmonary Disease, Chronic Obstructive

NCT00455923 2018-02-05

SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)

GlaxoSmithKline

Phase 4 Completed
100 enrolled 8 charts
LymphoidThoracic

Asthma, Lymphoma, Follicular, Bronchial Hyperreactivity

NCT00461500 2017-03-03

SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults

GlaxoSmithKline

Phase 4 Completed
81 enrolled 18 charts
Lymphoid

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡